Company: IXHL
Filing Date: 2025-04-03
Form Type: 8-K
Source: 0001213900-25-028373
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-03
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01

On April 3, 2025, Incannex Healthcare Inc.
completes Phase 2 enrollment in RePOSA Phase 2/3 trial of IHL-42X, an oral once-daily treatment for Obstructive Sleep Apnea (OSA). Further
information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item 8.01.

Item 9.01 Financial Statements and Exhibits.